BIOFORCE NANOSCIENCES HOLDINGS, INC. Stock-Based Compensation
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported Stock-Based Compensation of $158.00 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-10-23
- BIOFORCE NANOSCIENCES HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-09-30 was $0.00.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-06-30 was $0.00.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $158.00M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month |
|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $0.00 derived: sum of 2 quarters · filed 2020-10-23 | $158.00M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $158.00M 10-Q · filed 2020-07-22 | |
| 2020-03-31 | $158.00M 10-Q · filed 2020-05-04 |